Percutaneous coronary intervention (PCI) serves as a standard treatment for patients with unprotected left main coronary artery disease. Clinicians often debate whether IVUS-guided PCI provides superior long-term clinical outcomes compared to traditional angiography-guided techniques. The international, multicenter OPTIMAL trial recently addressed this uncertainty by comparing these two imaging strategies in a large patient population.

The trial enrolled 806 patients who were randomly assigned to either ultrasound guidance or conventional angiography. Researchers followed the participants for a median of 2.9 years to monitor a composite primary endpoint. This endpoint included any stroke, myocardial infarction, revascularization, or death from any cause. Despite the theoretical advantages of intravascular imaging, the study results revealed no significant difference between the two groups. Specifically, 33.7% of patients in the ultrasound group experienced a primary event compared to 30.9% in the angiography group.

Long-Term Safety and Efficacy of IVUS-guided PCI

Furthermore, secondary analyses confirmed that individual rates of death, myocardial infarction, and revascularization remained remarkably similar across both cohorts. Safety events, including those related directly to the procedure, also showed no statistically significant divergence. Consequently, these findings suggest that while intravascular imaging offers detailed anatomical insights, it may not always translate into better patient-oriented outcomes for left main interventions when performed by experienced operators.

Physicians must consider that the OPTIMAL trial was conducted in high-volume centers where operators possess significant expertise. In addition, the trial highlights that high-quality angiographic guidance remains a robust and reliable approach for managing complex left main lesions. However, clinicians may still find intravascular ultrasound helpful for optimizing stent expansion or characterizing complex plaque morphology in individual cases. Therefore, the choice of imaging modality should reflect both institutional standards and the specific clinical context of the patient.

Frequently Asked Questions

What were the primary findings of the OPTIMAL trial regarding IVUS-guided PCI?

The trial found that IVUS-guided PCI did not reduce the incidence of a composite endpoint of stroke, myocardial infarction, revascularization, or death when compared to angiography-guided PCI over a 2.9-year period.

Does this mean IVUS is no longer necessary for left main interventions?

Not necessarily. While the OPTIMAL trial showed no clinical superiority for the primary endpoint, IVUS remains a valuable tool for optimizing stent placement and is still supported by various clinical guidelines for complex coronary lesions.

How did the safety profiles compare between the two imaging groups?

The rates of procedure-related and overall safety events were similar between the IVUS-guided and angiography-guided groups, indicating that both strategies are equally safe in experienced hands.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Testa L et al. IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease. N Engl J Med. 2026 Mar 30. doi: 10.1056/NEJMoa2600440. PMID: 41911017.

Stone GW et al. Clinical Outcome of Intravascular Ultrasound Guided Left Main Coronary Intervention. Journal of the American College of Cardiology. 2024;83(12):1120-1135.

Diletti R et al. IVUS-Guided vs. Angiography-Guided PCI in Complex Coronary Arteries: The IVUS-CHIP Trial. N Engl J Med. 2026 Mar 30. doi: 10.1056/NEJMoa2600441.